CJC-1295bụ ihe sịntetik, tetrasisteded peptide analogue nkehormone na-ewepụta homonụ na-eto eto (GHH), emebere kana-akpali ma na-akwado mmepụta nke hormone uto endogenous (GH). N'adịghị ka nwa amaala GHRH, nke nwere obere ndụ ọkara, CJC-1295 gụnyereTeknụzụ Mgbakwunye Mgbakwunye ọgwụ (DAC)., na-ekwe ka ọ na-ejikọta covalently na albumin n'ime ọbara namee ka ọkara ndụ ndụ ya dị ogologo karịa ụbọchị 8. Ihe ọhụrụ a na-eme CJC-1295 aAnalog GHRH na-eme ogologo ogenwere ikike dị ukwuu namgbochi ịka nká, ụkọ uto, usoro metabolic, ọrịa na-emebi ahụ ike, na ọgwụ na-emegharị ahụ.
CJC-1295 na-arụ ọrụ naGHRH nnatadị na sel somatotropic na pituitary anterior. Ọrụ ndu ya na-eṅomi nke GHRH nke ala, mana ọ nwere ogologo ndụ ogologo ndụ n'ihi mgbanwe DAC. Omume a kwadoro na-enyere akantọhapụ pulsatile kwụsiri ike nke GHna ụba mmepụta nkeIhe na-eto eto dị ka insulin 1 (IGF-1).
Mkpali nke nzuzo GH endogenous
Ogologo ogologo oge nke ọkwa IGF-1, na-akwado mmetụta anabolic
Enweghị nkụda mmụọ dị mkpama ọ bụ downregulation na-aga n'ihu iji
Mmezi lipolysis, njikọ protein, na mmụgharị cellular
Site n'ịkpalite ụzọ GH na IGF-1 nke anụ ahụ, CJC-1295 na-ezere ọtụtụ ihe ndọghachi azụ jikọtara ya na ọgwụgwọ GH exogenous, dị ka enweghị ike nnabata na nchegbu nchekwa.
N'ime ule ụlọ ọgwụ nke mbụ, CJC-1295 egosila:
Mmụba na-adịgide adịgide naGHnaIGF-1ọkwa ruo6-10 ụbọchịmgbe otu ntụtụ
E belataraugboro igba ogwutụnyere GHRH analogues ma ọ bụ GH injections kwa ụbọchị
Emelitere nnabata onye ọrịa yana nkwụsi ike nke homonụ
Ọmụmụ anụmanụ na ụmụ mmadụ egosila na CJC-1295:
Na-akwaliteuru muscle daberenana-ebelata abụba anụ ahụ, karịsịa abụba visceral
Na-akwalitenjigide nitrogen na njikọ proteinna skeletal muscle
Nwere ike inye aka na mgbake site nasarcopeniana ọnọdụ imefusị ahụ ike
Dika ọkwa GH na IGF-1 na-agbadata na afọ, a na-amụwanye CJC-1295 dị kamgbochi ịka nká akaka:
Meliteụra àgwànausoro mgbawa nke circadian
kwaliteelasticity akpụkpọ, ọkpụkpụ njupụta, naọrụ mgbochi ọrịa
Nkwadoike metabolismnaike ọgwụgwụ na-eguzogide
CJC-1295 na-egosi nkwa na ikwu okwuinsulin iguzogideMetabolism syndrome na-agụnye:
Na-emeziwanyeeji glucose eme ihe
Na-akwalitelipid oxidationnametabolism nke anụ ahụ adipose
Na-akwadonjikwa ibun'ime ndị buru ibu ma ọ bụ tupu ọrịa shuga
At Ndị otu Gentolex, anyịCJC-1295 APIeji emeputaNgwakọta peptide siri ike (SPPS)ma mee ka ọ dị ọcha site na iji HPLC iji nweta ịdị ọcha dị elu na nkwekọ-na-batch.
Ịdị ọcha ≥ 99%(HPLC kwadoro)
Ihe mgbaze dị ala na ọla dị arọ
Endotoxin na-enweghị, ụzọ njikọ njikọ na-abụghị nke immunogen
Dị naomenala quantity: milligram ka kilogram ọnụ ọgụgụ
A na-ahụta CJC-1295 dị ka otu n'ime analogues GHRH na-ekwe nkwa ogologo oge, yana ngwa nwere ike na:
Usoro ọgwụgwọ ụkọ GH ndị okenye
Nlekọta ihe mejupụtara ahụ na oke ibu na ịka nká
Ndozigharị site na mfu ahụ ma ọ bụ trauma
Nkwalite arụmọrụ na mgbake na ntọala ụlọ ọgwụ ma ọ bụ egwuregwu
Nkwado ọgwụgwọ na ike ọgwụgwụ na-adịghị ala ala, fibromyalgia, na neuroendocrine adịghị mma
Ọnwụnwa ụlọ ọgwụ na-aga n'ihu na-enyocha iji ya dị ka ihe ọzọGH recombinant, karịsịa na ndị mmadụ na-achọmma, ọzọ physiological mgbanwe homonụ.